Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2012 by National Cancer Institute (NCI).
Recruitment status was  Recruiting
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI) Identifier:
First received: May 14, 2010
Last updated: December 6, 2012
Last verified: December 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: July 2016 (Final data collection date for primary outcome measure)